Literature DB >> 26811209

High dose rate brachytherapy for prostate cancer: Standard of care and future direction.

N Thiruthaneeswaran1, P J Hoskin2.   

Abstract

High dose rate brachytherapy is a highly conformal method of radiation dose escalation for prostate cancer and one of several treatment options for men with localised disease. The large doses per fraction exploit the low alpha/beta ratio of prostate cancer cells so that biological radiation dose delivered is substantially greater than that achieved with conventional external beam delivery. This review article presents contemporary data on the rationale for high dose rate brachytherapy including treatment technique and future directions.
Copyright © 2016 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Adénocarcinome prostatique; Antigène spécifique de la prostate; Carcinoma; PSA; Prostatic; TRUS; Traitement; Treatment; Échographie

Mesh：

Substances：

Year:  2016        PMID： 26811209     DOI： 10.1016/j.canrad.2016.01.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN： 1278-3218            Impact factor:   1.018


  3 in total

1.  Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy.

Authors:  David Buchser; Alfonso Gomez-Iturriaga; J Ignacio Rodriguez Melcon; Francisco Casquero; Roberto Llarena; Jon Cacicedo; Pedro Bilbao
Journal:  J Contemp Brachytherapy       Date:  2016-12-06

2.  Pre-implant magnetic resonance and transrectal ultrasound imaging in high-dose-rate prostate brachytherapy: comparison of prostate volumes, craniocaudal extents, and contours.

Authors:  Simone Grisotto; Annamaria Cerrotta; Brigida Pappalardi; Mauro Carrara; Antonella Messina; Chiara Tenconi; Riccardo Valdagni; Carlo Fallai
Journal:  J Contemp Brachytherapy       Date:  2018-08-31

3.  Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation.

Authors:  Christopher W Smith; Ryan Alfano; Douglas Hoover; Kathleen Surry; David D'Souza; Jonathan Thiessen; Irina Rachinsky; John Butler; Jose A Gomez; Mena Gaed; Madeleine Moussa; Joseph Chin; Stephen Pautler; Glenn S Bauman; Aaron D Ward
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.